Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CODX OTCMKTS:NIMU NASDAQ:NXL NYSEAMERICAN:VTAK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCODXCo-Diagnostics$2.49-3.1%$3.81$1.26▼$46.50$9.47M2.84617,512 shs158,874 shsNIMUNon-Invasive Monitoring Systems$0.08+30.8%$0.06$0.00▼$0.09$9.29M-0.4438,462 shs23,025 shsNXLNexalin Technology$0.47+14.4%$0.41$0.31▼$2.00$9.03M4238,102 shs428,324 shsVTAKCatheter Precision$0.58+3.6%$0.90$0.55▼$4.94$2.02M-1.0721.68 million shs53.69 million shsThe Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCODXCo-Diagnostics-3.11%-5.68%-34.13%+70.55%-68.93%NIMUNon-Invasive Monitoring Systems+30.83%+30.83%-5.42%+12.14%+1,814.63%NXLNexalin Technology+14.36%+12.98%+15.97%+0.97%-54.02%VTAKCatheter Precision+3.57%-57.66%-44.76%-35.14%-86.31%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCODXCo-Diagnostics$2.49-3.1%$3.81$1.26▼$46.50$9.47M2.84617,512 shs158,874 shsNIMUNon-Invasive Monitoring Systems$0.08+30.8%$0.06$0.00▼$0.09$9.29M-0.4438,462 shs23,025 shsNXLNexalin Technology$0.47+14.4%$0.41$0.31▼$2.00$9.03M4238,102 shs428,324 shsVTAKCatheter Precision$0.58+3.6%$0.90$0.55▼$4.94$2.02M-1.0721.68 million shs53.69 million shsThe Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCODXCo-Diagnostics-3.11%-5.68%-34.13%+70.55%-68.93%NIMUNon-Invasive Monitoring Systems+30.83%+30.83%-5.42%+12.14%+1,814.63%NXLNexalin Technology+14.36%+12.98%+15.97%+0.97%-54.02%VTAKCatheter Precision+3.57%-57.66%-44.76%-35.14%-86.31%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCODXCo-Diagnostics 2.00Hold$67.502,610.84% UpsideNIMUNon-Invasive Monitoring Systems 0.00N/AN/AN/ANXLNexalin Technology 1.00SellN/AN/AVTAKCatheter Precision 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest VTAK, NIMU, CODX, and NXL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/8/2026NXLNexalin Technology Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)6/11/2026CODXCo-Diagnostics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/26/2026CODXCo-Diagnostics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)(Data available from 7/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCODXCo-Diagnostics$620K14.82N/AN/A$9.14 per share0.27NIMUNon-Invasive Monitoring SystemsN/AN/AN/AN/A($0.01) per shareN/ANXLNexalin Technology$300K34.41N/AN/A$0.20 per share2.35VTAKCatheter Precision$820K2.55$5.80 per share0.10$3.82 per share0.15Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCODXCo-Diagnostics-$46.90M-$15.77N/AN/AN/A-6,760.63%-164.92%-141.15%8/14/2026 (Estimated)NIMUNon-Invasive Monitoring Systems-$220KN/AN/AN/AN/AN/AN/A-2,364.44%N/ANXLNexalin Technology-$8.22M-$0.47N/AN/AN/A-3,018.12%-191.88%-166.43%9/2/2026 (Estimated)VTAKCatheter Precision-$17.18MN/AN/AN/AN/A-1,297.56%-76.51%-21.61%8/17/2026 (Estimated)Latest VTAK, NIMU, CODX, and NXL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/18/2026Q1 2026VTAKCatheter Precision-$20.90-$1.39+$19.51-$1.39$1.60 million$0.43 million5/14/2026Q1 2026CODXCo-Diagnostics-$3.75-$4.06-$0.31-$4.06$0.13 million$0.15 million5/8/2026Q1 2026NXLNexalin Technology-$0.10-$0.11-$0.01-$0.11$0.02 million$0.01 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCODXCo-DiagnosticsN/AN/AN/AN/AN/ANIMUNon-Invasive Monitoring SystemsN/AN/AN/AN/AN/ANXLNexalin TechnologyN/AN/AN/AN/AN/AVTAKCatheter PrecisionN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCODXCo-DiagnosticsN/A2.282.09NIMUNon-Invasive Monitoring SystemsN/A0.020.02NXLNexalin TechnologyN/A4.073.85VTAKCatheter Precision0.350.060.06Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCODXCo-Diagnostics14.99%NIMUNon-Invasive Monitoring Systems0.12%NXLNexalin Technology0.65%VTAKCatheter Precision20.34%Insider OwnershipCompanyInsider OwnershipCODXCo-Diagnostics5.40%NIMUNon-Invasive Monitoring Systems63.50%NXLNexalin Technology25.26%VTAKCatheter Precision5.86%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCODXCo-Diagnostics1003.69 million3.49 millionOptionableNIMUNon-Invasive Monitoring Systems3154.81 million56.51 millionNot OptionableNXLNexalin Technology322.01 million16.45 millionNot OptionableVTAKCatheter Precision143.61 million3.40 millionN/AVTAK, NIMU, CODX, and NXL HeadlinesRecent News About These CompaniesVTAK Announces Preliminary Second Quarter Record Revenue in Excess of $1 millionJuly 15 at 5:24 PM | finance.yahoo.comCatheter Precision reports preliminary revenue of $1M for quarter ended June 30July 15 at 5:24 PM | seekingalpha.comCatheter Precision (NYSEAMERICAN:VTAK) Stock Price Down 16.8% - What's Next?July 10, 2026 | americanbankingnews.comCatheter Precision (AMEX:VTAK) Stock, Short Interest ReportJuly 9, 2026 | benzinga.comCatheter Precision Inc.July 9, 2026 | marketwatch.comCatheter Precision (VTAK) stock soars nearly 27% after-hours: Here's why it is trendingJuly 8, 2026 | msn.comFlyte Partners with LifeVac to Equip Every Vision Jet with Life-Saving EquipmentJuly 7, 2026 | globenewswire.comCatheter Precision, Inc. Announces Issuance of Two Key PatentsJuly 6, 2026 | markets.businessinsider.comFlyte Slides on New Digital Booking ProgramJuly 2, 2026 | baystreet.caFlyte Announces Successful Launch of New Direct-to-Consumer Booking PlatformJuly 2, 2026 | globenewswire.comBreaking Down 3 Trades from ItalyJune 26, 2026 | banyanhill.comBWhat's going on with Catheter Precision stock on Friday?June 26, 2026 | msn.comCatheter Precision (VTAK) stock jumps over 17% after hours: Here's what is going onJune 24, 2026 | msn.comCatheter Precision Inc VTAKJune 23, 2026 | morningstar.comMCatheter Precision, Inc. Announces Allowance of Key Intellectual PropertyJune 23, 2026 | markets.businessinsider.comCatheter Precision, Inc.: Flyte Expands Strategic Relationship With Volato By Joining Vaunt PlatformJune 11, 2026 | finanznachrichten.deFlyte, a Subsidiary of Catheter Precision, Inc., Announces Strategic Investment in Volato Group, Inc.June 8, 2026 | quiverquant.comQFlyte (VTAK) Makes Strategic Investment in Volato (SOAR)June 8, 2026 | globenewswire.comCatheter Precision Makes Strategic Investment in Volato GroupJune 8, 2026 | tipranks.comFLYTE ACTIVATES HIGH-FREQUENCY MEMORIAL DAY WEEKEND FLIGHT NETWORK TO CAPTURE SURGING NORTHEAST DEMANDMay 21, 2026 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeVTAK, NIMU, CODX, and NXL Company DescriptionsCo-Diagnostics NASDAQ:CODX$2.49 -0.08 (-3.11%) Closing price 07/15/2026 04:00 PM EasternExtended Trading$2.49 0.00 (0.00%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.Non-Invasive Monitoring Systems OTCMKTS:NIMU$0.08 +0.02 (+30.83%) As of 07/15/2026 02:22 PM EasternNon-Invasive Monitoring Systems, Inc. does not have significant operations. Previously, it was involved in the research, development, manufacture, marketing, and sale of non-invasive, motorized, and whole body periodic acceleration platforms. The company was incorporated in 1980 and is based in Miami, Florida.Nexalin Technology NASDAQ:NXL$0.47 +0.06 (+14.36%) Closing price 07/15/2026 04:00 PM EasternExtended Trading$0.45 -0.02 (-4.90%) As of 04:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.Catheter Precision NYSEAMERICAN:VTAK$0.58 +0.02 (+3.57%) Closing price 07/15/2026 04:10 PM EasternExtended Trading$0.65 +0.07 (+11.90%) As of 04:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company sells it products through distribution partners, independent sales agents, and direct employees. Catheter Precision, Inc. is based in Fort Mill, South Carolina. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings Why ASML’s AI Monopoly Is Still Getting Stronger Alphabet’s AI Spending Question Looms Over Q2 Earnings CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks 2 Quantum Stocks That Could Challenge IonQ’s Leadership 3 Small-Cap Stocks Trading Under $10 With Room to Run Plot Twist: 12 States Could Stall the Paramount-Warner Bros. Discovery Mega-Merger Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
